Survival Efficacy and Safety of Small Versus Large Doxorubicin DrugEluting Beads TACE Chemoembolization in Patients with Unresectable HCC
FINAL (2)-150.png
BackTABLEfinal-2tone_edited.png

© 2020 by Backtable. All rights reserved.

Survival Efficacy and Safety of Small Versus Large Doxorubicin Drug-Eluting Beads TACE Chemoembolization in Patients with Unresectable HCC

Trouble viewing this article?

The purpose of this study was to investigate the overall survival, efficacy, and safety of small (100–300 μm) versus large (300–500 and 500–700 μm) doxorubicin drugeluting beads transarterial chemoembolization (DEB TACE) in patients with unresectable hepatocellular carcinoma (HCC).

Join The Discussion

Related Content

No related content.

Podcast

Bridging to Transplant for HCC

Demo Video

SIS Radial Access in Oncologic Embolization

Demo Video

Increasing Embolization Efficiency with the Surefire Infusion System

Podcast

Building an Interventional Ocology Program

Disclaimer: The Materials available BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients.